F
PFE icon

FolioMetrix’s Pfizer PFE Stock Holding History

FolioMetrix’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$80K Sell
2,783
-1,855
-40% -$60.5K 0.03% 213
2015
Q1 		$153K Hold
4,638
– – 0.08% 170
2014
Q4 		$130K Buy
+4,638
New +$133K 0.09% 175

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FolioMetrix's PFE Position: Q2 2015 in Review

FolioMetrix reduced its Pfizer (PFE) stake by 40% in Q2 2015, selling an estimated $60.5K and leaving 2,783 shares worth $80K. The position accounts for 0.03% of the portfolio, ranked #213.

FolioMetrix first reported a position in PFE in Q4 2014 and has held it in 3 quarters since. The position peaked at $153K in Q1 2015. 1,888 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • FolioMetrix held 2,783 shares of Pfizer worth $80K as of Q2 2015.
  • FolioMetrix sold 1,855 Pfizer shares in Q2 2015, an estimated $60.5K.
  • Pfizer made up 0.03% of FolioMetrix's portfolio in Q2 2015, its #213 holding.
  • FolioMetrix first reported a position in Pfizer in Q4 2014 and has held it in 3 quarters since.
  • FolioMetrix's Pfizer position peaked at $153K in Q1 2015.
  • 1,888 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.